AngioDynamics, Inc. v. C.R. Bard, Inc. et al
Filing
440
ORDER: with rulings on objections to deposition designations for witness Blaber. The Court notes that its rulings are limited to the deposition designations and do not constitute rulings on the admissibility of related exhibits. Signed by Chief Judge Brenda K. Sannes on 9/20/2022. (nmk)
<![CDATA[
AngioDynamics v. Bard, N.D.N.Y. 17-598
Bard's September 17, 2022 Submission to Court
Case 1:17-cv-00598-BKS-CFH Document 440 Filed 09/20/22 Page 1 of 14
Blaber, David
Bard's Corrected and Revised Objections and Counter-Designations to AngioDynamics' 9/13/2022 Affirmative Designations
AngioDynamics'
Bard's Objections to Affirmative
Bard's Counter-Designations
Date of Testimony
Affirmative
Designations
Designations
November 14, 2019
7:3 -7:5
November 14, 2019
9:17 -9:19
November 14, 2019
9:20 -9:20
incomplete/incomprehensible
November 14, 2019
9:20 -9:21
November 14, 2019
11:5 -11:5
incomplete/incomprehensible
November 14, 2019
11:5 -11:13
November 14, 2019
11:19 -11:25
November 14, 2019
12:1 -12:7
November 14, 2019
13:8 -13:8
incomplete/incomprehensible
November 14, 2019
27:19 -27:19
incomplete/incomprehensible
November 14, 2019
27:19 -29:22
November 14, 2019
34:12 -34:12
incomplete/incomprehensible
November 14, 2019
34:12 -34:15
November 14, 2019
34:16 -35:13
Incomplete/incomprehensible; P-104,
35:17 -35:17
Relevance, 403 - confusing/prejudicial
November 14, 2019
Blaber, David
November 14, 2019
Blaber, David
November 14, 2019
Blaber, David
November 14, 2019
Blaber, David
November 14, 2019
Blaber, David
November 14, 2019
Blaber, David
November 14, 2019
Blaber, David
November 14, 2019
Blaber, David
November 14, 2019
Name of Deponent
Blaber, David
Blaber, David
Blaber, David
Blaber, David
Blaber, David
Blaber, David
Blaber, David
Blaber, David
Blaber, David
Blaber, David
Blaber, David
Blaber, David
Blaber, David
Blaber, David
35:17 -35:18
36:1 -36:5
36:9 -36:11
36:12 -37:22
37:25 -38:9
38:15 -38:22
38:25 -39:5
39:9 -39:11
P-104, Relevance, 403 - confusing/prejudicial
P-104, Relevance, 403 - confusing/prejudicial
P-104, Relevance, 403 - confusing/prejudicial
P-104, Relevance, 403 - confusing/prejudicial
P-104, Relevance, 403 - confusing/prejudicial
P-104, Relevance, 403 - confusing/prejudicial
P-104, Relevance, 403 - confusing/prejudicial
P-104, Relevance, 403 - confusing/prejudicial
Court’s Ruling
Overruled
Overruled
Sustained
Overruled
Overruled
Overruled
Overruled
Overruled
Overruled
Overruled
Overruled
Overruled
Overruled
Overruled
AngioDynamics v. Bard, N.D.N.Y. 17-598
Bard's September 17, 2022 Submission to Court
Case 1:17-cv-00598-BKS-CFH Document 440 Filed 09/20/22 Page 2 of 14
Name of Deponent
Date of Testimony
Blaber, David
November 14, 2019
Blaber, David
November 14, 2019
Blaber, David
November 14, 2019
Blaber, David
November 14, 2019
Blaber, David
November 14, 2019
Blaber, David
November 14, 2019
Blaber, David
November 14, 2019
Blaber, David
November 14, 2019
Blaber, David
November 14, 2019
Blaber, David
November 14, 2019
Blaber, David
November 14, 2019
Blaber, David
November 14, 2019
Blaber, David
November 14, 2019
Blaber, David
November 14, 2019
Blaber, David
Blaber, David
November 14, 2019
November 14, 2019
AngioDynamics'
Bard's Objections to Affirmative
Affirmative
Designations
Designations
39:15 -39:18
39:19 -39:21
39:24 -39:24
39:25 -40:1
40:3 -40:4
40:5 -40:6
40:8 -40:8
40:15 -40:24
40:25 -42:8
42:11 -42:14
42:15 -43:3
43:14 -44:6
44:8 -44:11
44:14 -44:15
47:8 -49:11
49:25 -50:20
P-104, Relevance, 403 - confusing/prejudicial
P-104, Relevance, 403 - confusing/prejudicial
P-104, Relevance, 403 - confusing/prejudicial
P-104, Relevance, 403 - confusing/prejudicial
P-104, Relevance, 403 - confusing/prejudicial
P-104, Relevance, 403 - confusing/prejudicial
P-104, Relevance, 403 - confusing/prejudicial
P-104, Relevance, 403 - confusing/prejudicial
P-104, Relevance, 403 - confusing/prejudicial
P-104, Relevance, 403 - confusing/prejudicial
P-104, Relevance, 403 - confusing/prejudicial
P-104, Relevance, 403 - confusing/prejudicial
P-104, Relevance, 403 - confusing/prejudicial
P-104, Relevance, 403 - confusing/prejudicial
P-093, Relevance; 801/802 - Hearsay (hearsay
within monthly report)
Bard's Counter-Designations
Court’s Ruling
Overruled
Overruled
Overruled
Overruled
Overruled
Overruled
Overruled
Overruled
Overruled
Overruled
Overruled
Overruled
Overruled
Overruled
Overruled
AngioDynamics v. Bard, N.D.N.Y. 17-598
Bard's September 17, 2022 Submission to Court
Name of Deponent
Blaber, David
Blaber, David
Blaber, David
Blaber, David
Blaber, David
Blaber, David
Case 1:17-cv-00598-BKS-CFH Document 440 Filed 09/20/22 Page 3 of 14
Date of Testimony
November 14, 2019
AngioDynamics'
Bard's Objections to Affirmative
Bard's Counter-Designations
Affirmative
Designations
Designations
P-054 801/802 - Hearsay (e.g., page 2, Wheeler
54:6 -54:10
statements relayed by Rae; page 3, email from
Wheeler (UCH))
281:13-22, 281:24-282:3
Court’s Ruling
Overruled
54:20 -55:21
P-054 801/802 - Hearsay (e.g., page 2, Wheeler
statements relayed by Rae; page 3, email from
Wheeler (UCH))
281:13-22, 281:24-282:3
Overruled
55:22 -56:15
November 14, 2019
P-054 801/802 - Hearsay (e.g., page 2, Wheeler
statements relayed by Rae; page 3, email from
Wheeler (UCH))
281:13-22, 281:24-282:3
Sustained
(hearsay)
57:20 -58:10
November 14, 2019
P-054 801/802 - Hearsay (e.g., page 2, Wheeler
statements relayed by Rae; page 3, email from
Wheeler (UCH))
281:13-22, 281:24-282:3
Sustained
(hearsay)
58:11 -59:4
November 14, 2019
P-054 801/802 - Hearsay (e.g., page 2, Wheeler
statements relayed by Rae; page 3, email from
Wheeler (UCH))
281:13-22, 281:24-282:3
Sustained
(hearsay)
59:13 -59:22
November 14, 2019
P-054 801/802 - Hearsay (e.g., page 2, Wheeler
statements relayed by Rae; page 3, email from
Wheeler (UCH))
281:13-22, 281:24-282:3
Sustained
(hearsay)
60:5 -60:25
P-054 801/802 - Hearsay (e.g., page 2, Wheeler
statements relayed by Rae; page 3, email from
Wheeler (UCH))
281:13-22, 281:24-282:3
Sustained as to
60:5-60:17
November 14, 2019
Blaber, David
Blaber, David
November 14, 2019
November 14, 2019
Blaber, David
November 14, 2019
Blaber, David
November 14, 2019
Blaber, David
November 14, 2019
Blaber, David
November 14, 2019
Blaber, David
November 14, 2019
61:22 -62:7
66:3 -67:2
68:23 -70:3
71:1 -71:5
71:10 -71:10
71:11 -71:17
P-088 801/802 - Hearsay (e.g., page one: "I
spoke to the VP of Supply Chain . . .")
P-088 801/802 - Hearsay (e.g., page one: "I
spoke to the VP of Supply Chain . . .")
P-088 801/802 - Hearsay (e.g., page one: "I
spoke to the VP of Supply Chain . . .")
P-088 801/802 - Hearsay (e.g., page one: "I
spoke to the VP of Supply Chain . . .")
P-088 801/802 - Hearsay (e.g., page one: "I
spoke to the VP of Supply Chain . . .")
Overruled
Sustained as to
69:9-70:3
Sustained
Sustained
Sustained
AngioDynamics v. Bard, N.D.N.Y. 17-598
Bard's September 17, 2022 Submission to Court
Case 1:17-cv-00598-BKS-CFH Document 440 Filed 09/20/22 Page 4 of 14
Name of Deponent
Date of Testimony
Blaber, David
November 14, 2019
Blaber, David
November 14, 2019
Blaber, David
Blaber, David
Blaber, David
Blaber, David
Blaber, David
Blaber, David
Blaber, David
Blaber, David
Blaber, David
Blaber, David
November 14, 2019
November 14, 2019
November 14, 2019
November 14, 2019
November 14, 2019
November 14, 2019
November 14, 2019
November 14, 2019
November 14, 2019
November 14, 2019
Blaber, David
Blaber, David
November 14, 2019
November 14, 2019
Blaber, David
November 14, 2019
Blaber, David
November 14, 2019
Blaber, David
November 14, 2019
Blaber, David
Blaber, David
November 14, 2019
November 14, 2019
AngioDynamics'
Bard's Objections to Affirmative
Affirmative
Designations
Designations
P-088 801/802 - Hearsay (e.g., page one: "I
71:19 -71:20
spoke to the VP of Supply Chain . . .")
P-088 801/802 - Hearsay (e.g., page one: "I
71:24 -72:6
spoke to the VP of Supply Chain . . .")
P-088 801/802 - Hearsay (e.g., page one: "I
72:8 -72:10
spoke to the VP of Supply Chain . . .")
133:12 -133:12
133:15 -133:25
134:1 -134:2
138:15 -139:10
139:13 -139:17
139:18 -140:9
140:16 -140:21
140:23 -141:3
141:5 -141:5
141:6 -141:11
141:13 -141:13
Bard's Counter-Designations
71:21-23
Court’s Ruling
Sustained
Sustained
Sustained
Sustained as to
141:10-11
Sustained
Relevance, 403 (prejudice)
Relevance, 403 (prejudice)
142:4 -143:3
P-051 403, prejudice, duplicative/cumulative
(introduced in O'Connell designations)
285:16-286:5, 286:12-21, 286:24287:11, 287:15-20, 287:22-288:10
Overruled
143:4 -143:25
P-051 403, prejudice, duplicative/cumulative
(introduced in O'Connell designations)
285:16-286:5, 286:12-21, 286:24287:11, 287:15-20, 287:22-288:10
Overruled
144:1 -144:25
P-051 403, prejudice, duplicative/cumulative
(introduced in O'Connell designations)
285:16-286:5, 286:12-21, 286:24287:11, 287:15-20, 287:22-288:10
Overruled
145:1 -145:3
P-051 403, prejudice, duplicative/cumulative
(introduced in O'Connell designations)
Relevance, 403 (prejudice)
146:2 -146:4
145:4-13, 285:16-286:5, 286:12-21,
286:24-287:11, 287:15-20, 287:22288:10
Overruled
Overruled
AngioDynamics v. Bard, N.D.N.Y. 17-598
Bard's September 17, 2022 Submission to Court
Name of Deponent
Case 1:17-cv-00598-BKS-CFH Document 440 Filed 09/20/22 Page 5 of 14
Date of Testimony
AngioDynamics'
Bard's Objections to Affirmative
Affirmative
Designations
Designations
146:6 -146:12
Blaber, David
Blaber, David
November 14, 2019
November 14, 2019
Blaber, David
Blaber, David
Blaber, David
Blaber, David
Blaber, David
Blaber, David
Blaber, David
Blaber, David
Blaber, David
Blaber, David
Court’s Ruling
Overruled
147:14 -147:19
152:2 -153:9
Blaber, David
P-051 403, prejudice, duplicative/cumulative
(introduced in O'Connell designations)
Bard's Counter-Designations
November 14, 2019
P-058 801/802 - Hearsay (page 2, email from
Sears), duplicative/cumulative (introduced in
O'Connell designations)
Sustained as to
152:10-13
("…talking
about")
153:16 -154:1
Overruled
November 14, 2019
P-058 801/802 - Hearsay (page 2, email from
Sears), duplicative/cumulative (introduced in
O'Connell designations)
154:2 -155:3
Overruled
November 14, 2019
P-058 801/802 - Hearsay (page 2, email from
Sears), duplicative/cumulative (introduced in
O'Connell designations)
159:4 -159:12
Sustained
November 14, 2019
P-058 801/802 - Hearsay (page 2, email from
Sears), duplicative/cumulative (introduced in
O'Connell designations)
159:14 -159:22
November 14, 2019
P-058 801/802 - Hearsay (page 2, email from
Sears), duplicative/cumulative (introduced in
O'Connell designations)
Sustained as to
159:14-159:19
160:22 -161:4
P-058 801/802 - Hearsay (page 2, email from
Sears), duplicative/cumulative (introduced in
O'Connell designations)
Overruled
(170:13-18) misstates document, misstates prior
testimony
Sustained
November 14, 2019
November 14, 2019
November 14, 2019
November 14, 2019
November 14, 2019
November 14, 2019
Blaber, David
November 14, 2019
Blaber, David
Blaber, David
November 14, 2019
November 14, 2019
161:6 -161:15
161:17 -161:25
165:23 -165:24
166:3 -167:7
167:18 -168:3
169:9 -170:18
170:20 -170:22
171:11 -171:23
Misstates document, misstates prior testimony
Sustained
AngioDynamics v. Bard, N.D.N.Y. 17-598
Bard's September 17, 2022 Submission to Court
Name of Deponent
Case 1:17-cv-00598-BKS-CFH Document 440 Filed 09/20/22 Page 6 of 14
Date of Testimony
Blaber, David
November 14, 2019
Blaber, David
November 14, 2019
Blaber, David
November 14, 2019
Blaber, David
November 14, 2019
Blaber, David
AngioDynamics'
Bard's Objections to Affirmative
Affirmative
Designations
Designations
P-174 Hearsay (e.g. "We just had another major 282:4-8, 282:10-14, 282:16-283:4,
account give up on" the Vasanova trial)
283:6-18, 283:20-284:10, 284:12-17
Overruled
173:23 -174:3
P-174 Hearsay (e.g. "We just had another major 282:4-8, 282:10-14, 282:16-283:4,
account give up on" the Vasanova trial)
283:6-18, 283:20-284:10, 284:12-17
Overruled
174:23 -175:14
P-174 Hearsay (e.g. "We just had another major 282:4-8, 282:10-14, 282:16-283:4,
account give up on" the Vasanova trial)
283:6-18, 283:20-284:10, 284:12-17
Overruled
176:1 -176:17
P-174 Hearsay (e.g. "We just had another major 282:4-8, 282:10-14, 282:16-283:4,
account give up on" the Vasanova trial)
283:6-18, 283:20-284:10, 284:12-17
Overruled
177:18 -178:12
P-174 Hearsay (e.g. "We just had another major 282:4-8, 282:10-14, 282:16-283:4,
account give up on" the Vasanova trial)
283:6-18, 283:20-284:10, 284:12-17
Overruled
November 14, 2019
November 14, 2019
178:19 -179:1
Blaber, David
November 14, 2019
179:2 -179:4
Blaber, David
November 14, 2019
179:19 -180:19
Blaber, David
November 14, 2019
Court’s Ruling
173:17 -173:19
178:15 -178:15
Blaber, David
Bard's Counter-Designations
P-121 801/802 - Hearsay (e.g., page 1:
"Multiple reports this month . . ."); 403 - More
Prejudical than Probative (e.g., page 1: "shit")
282:4-8, 282:10-14, 282:16-283:4,
283:6-18, 283:20-284:10, 284:12-17
P-121 801/802 - Hearsay (e.g., page 1:
"Multiple reports this month . . ."); 403 - More
Prejudical than Probative (e.g., page 1: "shit")
282:4-8, 282:10-14, 282:16-283:4,
283:6-18, 283:20-284:10, 284:12-17
P-121 801/802 - Hearsay (e.g., page 1:
"Multiple reports this month . . ."); 403 - More
Prejudical than Probative (e.g., page 1: "shit")
282:4-8, 282:10-14, 282:16-283:4,
283:6-18, 283:20-284:10, 284:12-17
P-121 801/802 - Hearsay (e.g., page 1:
"Multiple reports this month . . ."); 403 - More
Prejudical than Probative (e.g., page 1: "shit")
282:4-8, 282:10-14, 282:16-283:4,
283:6-18, 283:20-284:10, 284:12-17
Overruled
Overruled
Overruled
Sustained as to
180:12-19
AngioDynamics v. Bard, N.D.N.Y. 17-598
Bard's September 17, 2022 Submission to Court
Name of Deponent
Case 1:17-cv-00598-BKS-CFH Document 440 Filed 09/20/22 Page 7 of 14
Date of Testimony
AngioDynamics'
Bard's Objections to Affirmative
Affirmative
Designations
Designations
180:23 -182:17
Blaber, David
Blaber, David
Blaber, David
November 14, 2019
November 14, 2019
November 14, 2019
Blaber, David
November 14, 2019
Blaber, David
Blaber, David
Blaber, David
Blaber, David
November 14, 2019
November 14, 2019
November 14, 2019
November 14, 2019
Blaber, David
November 14, 2019
Blaber, David
November 14, 2019
Blaber, David
November 14, 2019
Blaber, David
November 14, 2019
Bard's Counter-Designations
P-121 801/802 - Hearsay (e.g., page 1:
"Multiple reports this month . . ."); 403 - More
Prejudical than Probative (e.g., page 1: "shit");
401/402 - irrelevant, violates assurance that
designations would be "targeted to elements of 282:4-8, 282:10-14, 282:16-283:4,
AngioDynamics' case" (ECF 356)
283:6-18, 283:20-284:10, 284:12-17
November 14, 2019
Blaber, David
November 14, 2019
Sustained as to
180:23-181:16
185:7 -185:14
186:10 -187:20
282:4-8, 282:10-14, 282:16-283:4,
283:6-18, 283:20-284:10, 284:12-17
282:4-8, 282:10-14, 282:16-283:4,
283:6-18, 283:20-284:10, 284:12-17
187:21 -188:5
188:16 -189:15
198:8 -199:3
199:5 -199:5
199:8 -200:25
205:1 -205:2
205:14 -206:9
206:10 -206:24
207:2 -207:19
P-356 401/402 - Relevance
P-356 401/402 - Relevance
P-356 401/402 - Relevance
P-356 401/402 - Relevance
282:4-8, 282:10-14, 282:16-283:4,
283:6-18, 283:20-284:10, 284:12-17
282:4-8, 282:10-14, 282:16-283:4,
283:6-18, 283:20-284:10, 284:12-17
282:4-8, 282:10-14, 282:16-283:4,
283:6-18, 283:20-284:10, 284:12-17
282:4-8, 282:10-14, 282:16-283:4,
283:6-18, 283:20-284:10, 284:12-17
P-356 401/402 - Relevance
216:11 -216:17
Overruled
Overruled
Overruled
Overruled
Overruled (does
not appear related
to P-356)
212:20 -213:19
Blaber, David
Court’s Ruling
282:4-8, 282:10-14, 282:16-283:4,
283:6-18, 283:20-284:10, 284:12-17
AngioDynamics v. Bard, N.D.N.Y. 17-598
Bard's September 17, 2022 Submission to Court
Name of Deponent
Case 1:17-cv-00598-BKS-CFH Document 440 Filed 09/20/22 Page 8 of 14
Date of Testimony
AngioDynamics'
Bard's Objections to Affirmative
Affirmative
Designations
Designations
216:20 -216:21
Blaber, David
November 14, 2019
Blaber, David
November 14, 2019
Blaber, David
November 14, 2019
Blaber, David
Blaber, David
217:5 -217:6
217:10 -218:8
Overruled
November 14, 2019
220:8 -221:17
Overruled
November 14, 2019
P-012 removed from P's exhibit list;
Foundation, 801/802 Hearsay; 401/402
Relevance; 403 Prejudice
November 14, 2019
November 14, 2019
November 14, 2019
226:2 -226:3
Blaber, David
Overruled
Overruled
225:23 -225:25
Blaber, David
Sustained (bates
number does not
match P-012)
P-012 removed from P's exhibit list;
Foundation, 801/802 Hearsay; 401/402
Relevance; 403 Prejudice
225:10 -225:19
Blaber, David
P-012 removed from P's exhibit list;
Foundation, 801/802 Hearsay; 401/402
Relevance; 403 Prejudice
P-090 401/402 - Relevance; 403 - More
Prejudicial than Probative
P-090 401/402 - Relevance; 403 - More
Prejudicial than Probative
Court’s Ruling
218:9 -220:7
224:15 -225:4
Blaber, David
Bard's Counter-Designations
November 14, 2019
P-113 801/802 - Hearsay (e.g., page 1: "she said
that she is aware . . ."), cumulative/duplicative 282:4-8, 282:10-14, 282:16-283:4,
(introduced in O'Connell designations)
283:6-18, 283:20-284:10, 284:12-17
P-113 801/802 - Hearsay (e.g., page 1: "she said
that she is aware . . ."), cumulative/duplicative 282:4-8, 282:10-14, 282:16-283:4,
(introduced in O'Connell designations)
283:6-18, 283:20-284:10, 284:12-17
P-113 801/802 - Hearsay (e.g., page 1: "she said
that she is aware . . ."), cumulative/duplicative 282:4-8, 282:10-14, 282:16-283:4,
(introduced in O'Connell designations)
283:6-18, 283:20-284:10, 284:12-17
P-113 801/802 - Hearsay (e.g., page 1: "she said
that she is aware . . ."), cumulative/duplicative 282:4-8, 282:10-14, 282:16-283:4,
(introduced in O'Connell designations)
283:6-18, 283:20-284:10, 284:12-17
Overruled
Sustained
Sustained
Sustained
AngioDynamics v. Bard, N.D.N.Y. 17-598
Bard's September 17, 2022 Submission to Court
Name of Deponent
Case 1:17-cv-00598-BKS-CFH Document 440 Filed 09/20/22 Page 9 of 14
Date of Testimony
AngioDynamics'
Bard's Objections to Affirmative
Affirmative
Designations
Designations
226:4 -226:9
Blaber, David
November 14, 2019
226:11 -226:15
Blaber, David
November 14, 2019
227:3 -227:14
Blaber, David
November 14, 2019
227:16 -228:24
Blaber, David
November 14, 2019
228:6 -228:24
Blaber, David
November 14, 2019
P-113 801/802 - Hearsay (e.g., page 1: "she said
that she is aware . . ."), cumulative/duplicative 282:4-8, 282:10-14, 282:16-283:4,
(introduced in O'Connell designations)
283:6-18, 283:20-284:10, 284:12-17
P-113 801/802 - Hearsay (e.g., page 1: "she said
that she is aware . . ."), cumulative/duplicative 282:4-8, 282:10-14, 282:16-283:4,
(introduced in O'Connell designations)
283:6-18, 283:20-284:10, 284:12-17
P-113 801/802 - Hearsay (e.g., page 1: "she said
that she is aware . . ."), cumulative/duplicative 282:4-8, 282:10-14, 282:16-283:4,
(introduced in O'Connell designations)
283:6-18, 283:20-284:10, 284:12-17
P-113 801/802 - Hearsay (e.g., page 1: "she said
that she is aware . . ."), cumulative/duplicative 282:4-8, 282:10-14, 282:16-283:4,
(introduced in O'Connell designations)
283:6-18, 283:20-284:10, 284:12-17
November 14, 2019
November 14, 2019
P-116 - 801/802 - Hearsay (e.g., page 1: "The
AngioDynamics rep . . ."),
duplicative/cumulative (introduced in O'Connell
designations)
232:4 -232:4
Blaber, David
P-113 801/802 - Hearsay (e.g., page 1: "she said
that she is aware . . ."), cumulative/duplicative 282:4-8, 282:10-14, 282:16-283:4,
(introduced in O'Connell designations)
283:6-18, 283:20-284:10, 284:12-17
P-113 801/802 - Hearsay (e.g., page 1: "she said
that she is aware . . ."), cumulative/duplicative
(introduced in O'Connell designations)
230:20-24
230:14 -230:19
Blaber, David
Bard's Counter-Designations
Court’s Ruling
Sustained
Sustained
Sustained as to
227:12-14
Sustained as to
227:16-17
(through
"statement") and
227:23-228:3
Sustained
Overruled
Overruled
AngioDynamics v. Bard, N.D.N.Y. 17-598
Bard's September 17, 2022 Submission to Court
Name of Deponent
Blaber, David
Blaber, David
Blaber, David
Blaber, David
Blaber, David
Blaber, David
Blaber, David
Case 1:17-cv-00598-BKS-CFH Document 440 Filed 09/20/22 Page 10 of 14
Date of Testimony
AngioDynamics'
Bard's Objections to Affirmative
Affirmative
Designations
Designations
Bard's Counter-Designations
Court’s Ruling
232:8 -232:21
Overruled
November 14, 2019
P-116 - 801/802 - Hearsay (e.g., page 1: "The
AngioDynamics rep . . ."),
duplicative/cumulative (introduced in O'Connell
designations)
233:2 -233:18
Sustained as to
233:3-9
November 14, 2019
P-116 - 801/802 - Hearsay (e.g., page 1: "The
AngioDynamics rep . . ."),
duplicative/cumulative (introduced in O'Connell
designations)
233:20 -233:21
Overruled
November 14, 2019
P-116 - 801/802 - Hearsay (e.g., page 1: "The
AngioDynamics rep . . ."),
duplicative/cumulative (introduced in O'Connell
designations)
233:22 -233:23
Sustained
November 14, 2019
P-116 - 801/802 - Hearsay (e.g., page 1: "The
AngioDynamics rep . . ."),
duplicative/cumulative (introduced in O'Connell
designations)
233:25 -234:11
Sustained
November 14, 2019
P-116 - 801/802 - Hearsay (e.g., page 1: "The
AngioDynamics rep . . ."),
duplicative/cumulative (introduced in O'Connell
designations)
234:25 -235:5
Overruled
November 14, 2019
P-116 - 801/802 - Hearsay (e.g., page 1: "The
AngioDynamics rep . . ."),
duplicative/cumulative (introduced in O'Connell
designations)
236:25 -237:1
Overruled
November 14, 2019
P-053 801/802 - Hearsay (e.g., page 3, "A little
concerned. I did contact Supply Chain at
Cleveland Clinic. They are using..."),
duplicative/cumulative (introduced in O'Connell
designations)
AngioDynamics v. Bard, N.D.N.Y. 17-598
Bard's September 17, 2022 Submission to Court
Name of Deponent
Blaber, David
Blaber, David
Blaber, David
Blaber, David
Blaber, David
Blaber, David
Case 1:17-cv-00598-BKS-CFH Document 440 Filed 09/20/22 Page 11 of 14
Date of Testimony
AngioDynamics'
Bard's Objections to Affirmative
Affirmative
Designations
Designations
Bard's Counter-Designations
Court’s Ruling
237:5 -238:6
Overruled
November 14, 2019
P-053 801/802 - Hearsay (e.g., page 3, "A little
concerned. I did contact Supply Chain at
Cleveland Clinic. They are using..."),
duplicative/cumulative (introduced in O'Connell
designations)
238:7 -238:18
Overruled
November 14, 2019
P-053 801/802 - Hearsay (e.g., page 3, "A little
concerned. I did contact Supply Chain at
Cleveland Clinic. They are using..."),
duplicative/cumulative (introduced in O'Connell
designations)
239:1 -239:19
Overruled
(inquiry)
November 14, 2019
P-053 801/802 - Hearsay (e.g., page 3, "A little
concerned. I did contact Supply Chain at
Cleveland Clinic. They are using..."),
duplicative/cumulative (introduced in O'Connell
designations)
239:25 -240:5
Overruled
November 14, 2019
P-053 801/802 - Hearsay (e.g., page 3, "A little
concerned. I did contact Supply Chain at
Cleveland Clinic. They are using..."),
duplicative/cumulative (introduced in O'Connell
designations)
240:11 -242:4
November 14, 2019
P-053 801/802 - Hearsay (e.g., page 3, "A little
concerned. I did contact Supply Chain at
Cleveland Clinic. They are using..."),
duplicative/cumulative (introduced in O'Connell
designations)
Sustained as to
240:19 ("She
wants…") 241:12
241:6 -241:16
See above.
Overruled as to
241:13-241:16
November 14, 2019
P-053 801/802 - Hearsay (e.g., page 3, "A little
concerned. I did contact Supply Chain at
Cleveland Clinic. They are using..."),
duplicative/cumulative (introduced in O'Connell
designations)
AngioDynamics v. Bard, N.D.N.Y. 17-598
Bard's September 17, 2022 Submission to Court
Name of Deponent
Blaber, David
Blaber, David
Case 1:17-cv-00598-BKS-CFH Document 440 Filed 09/20/22 Page 12 of 14
Date of Testimony
AngioDynamics'
Bard's Objections to Affirmative
Affirmative
Designations
Designations
242:3 -242:8
Overruled
November 14, 2019
242:13 -243:5
Overruled
November 14, 2019
P-053 801/802 - Hearsay (e.g., page 3, "A little
concerned. I did contact Supply Chain at
Cleveland Clinic. They are using..."),
duplicative/cumulative (introduced in O'Connell
designations)
243:6-11, 243:13-14
Vague
282:4-8, 282:10-14, 282:16-283:4,
283:6-18, 283:20-284:10, 284:12-17,
285:16-286:5, 286:12-21, 286:24287:11, 287:15-20, 287:22-288:10
November 14, 2019
Vague
282:4-8, 282:10-14, 282:16-283:4,
283:6-18, 283:20-284:10, 284:12-17,
285:16-286:5, 286:12-21, 286:24287:11, 287:15-20, 287:22-288:10
Vague
282:4-8, 282:10-14, 282:16-283:4,
283:6-18, 283:20-284:10, 284:12-17,
285:16-286:5, 286:12-21, 286:24287:11, 287:15-20, 287:22-288:10
246:25 -247:1
Blaber, David
November 14, 2019
247:2 -247:9
Blaber, David
November 14, 2019
247:12 -247:13
Blaber, David
Court’s Ruling
P-053 801/802 - Hearsay (e.g., page 3, "A little
concerned. I did contact Supply Chain at
Cleveland Clinic. They are using..."),
duplicative/cumulative (introduced in O'Connell
designations)
246:14 -246:23
Blaber, David
Bard's Counter-Designations
November 14, 2019
282:4-8, 282:10-14, 282:16-283:4,
283:6-18, 283:20-284:10, 284:12-17,
285:16-286:5, 286:12-21, 286:24287:11, 287:15-20, 287:22-288:10
Overruled
Overruled
Overruled
AngioDynamics v. Bard, N.D.N.Y. 17-598
Bard's September 17, 2022 Submission to Court
Name of Deponent
Case 1:17-cv-00598-BKS-CFH Document 440 Filed 09/20/22 Page 13 of 14
Date of Testimony
AngioDynamics'
Bard's Objections to Affirmative
Affirmative
Designations
Designations
November 14, 2019
282:4-8, 282:10-14, 282:16-283:4,
283:6-18, 283:20-284:10, 284:12-17,
285:16-286:5, 286:12-21, 286:24287:11, 287:15-20, 287:22-288:10
248:14 -249:10
Blaber, David
November 14, 2019
November 14, 2019
P-031 401/402 - Relevance; 801/802 - Hearsay
(e.g., page 2, "She specifically told us her 'go
live'..."; page 2, "Maria told us she's full steam
ahead..."), duplicative/cumulative (introduced in
O'Connell designations)
November 14, 2019
P-031 401/402 - Relevance; 801/802 - Hearsay
(e.g., page 2, "She specifically told us her 'go
live'..."; page 2, "Maria told us she's full steam
ahead..."), duplicative/cumulative (introduced in
O'Connell designations)
252:12 -252:12
Blaber, David
252:17 -253:6
Blaber, David
253:7 -253:9
Blaber, David
November 14, 2019
Blaber, David
November 14, 2019
Blaber, David
Blaber, David
November 14, 2019
November 14, 2019
267:24 -267:24
268:5 -268:20
269:7 -269:25
Court’s Ruling
282:4-8, 282:10-14, 282:16-283:4,
283:6-18, 283:20-284:10, 284:12-17,
285:16-286:5, 286:12-21, 286:24287:11, 287:15-20, 287:22-288:10
247:17 -248:12
Blaber, David
Bard's Counter-Designations
P-031 401/402 - Relevance; 801/802 - Hearsay
(e.g., page 2, "She specifically told us her 'go
live'..."; page 2, "Maria told us she's full steam
ahead..."), duplicative/cumulative (introduced in
O'Connell designations)
253:19-254:2, 254:5-15
P-061 - cumulative/duplicative (introduced in
O'Connell designations)
P-061 - cumulative/duplicative (introduced in
O'Connell designations)
Asked and answered
Overruled
Overruled
Overruled
Overruled
Overruled
Overruled
AngioDynamics v. Bard, N.D.N.Y. 17-598
Bard's September 17, 2022 Submission to Court
Case 1:17-cv-00598-BKS-CFH Document 440 Filed 09/20/22 Page 14 of 14
Name of Deponent
Date of Testimony
Blaber, David
November 14, 2019
AngioDynamics'
Bard's Objections to Affirmative
Affirmative
Designations
Designations
Asked and answered
270:1 -270:11
Dated: September 20, 2022
Bard's Counter-Designations
Court’s Ruling
Overruled
]]>
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
Why Is My Information Online?
